Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

Clinical trial NCT07283848 · WITHDRAWN

Trial details

NCT number: NCT07283848
Sponsor: Massachusetts General Hospital
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Stomach Adenocarcinoma Gastroesophageal Junction

Start date: 2026-02-01
Primary completion: 2026-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.